Clinical validation of a multi-model blood cfDNA methylation assay for early-stage gastrointestinal cancer screening
{{output}}
Background: Gastrointestinal (GI) tract cancers are the second leading cause of cancer-related mortality, often due to late detection. There is a critical need for non-invasive, highly sensitive biomarkers for early-stage cancer ... ...